Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
Trial details
- Registry ID
- NCT07901738
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in ChildrenNCT07901738 | PGEN | Phase 3 | Not yet recruiting | 2029-01Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |